Hary Alexander T, Chadha Smriti, Mercaldo Nathaniel, Smith Erin-Marie C, van der Kouwe André J W, Fischl Bruce, Mount Christopher, Kozanno Liana, Frosch Matthew P, Augustinack Jean C
Department of Radiology, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, 149 Thirteenth St, Suite 2301, Charlestown, MA, 02129, USA.
Computer Science and Artificial Intelligence Laboratory (CSAIL), Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
Acta Neuropathol Commun. 2025 Feb 28;13(1):44. doi: 10.1186/s40478-025-01957-6.
The locus coeruleus (LC) has been identified as a site that develops phosphorylated tau pathology earlier than cerebral cortex. We present data using high-resolution postmortem MRI and validated tau histopathology in controls and the earliest Braak and Braak (BB) stages (BBI-BBII) in LC. The high-resolution ex vivo MRI provides a 3D volume (quantitative), while the histology reveals tau specificity and severity burden (semi-quantitative). We mapped our highly regionally specific LC data onto high-resolution 3D MRI reconstructions of the same samples used in histology (n = 11). We noted significant structural subatrophy between BB 0 and II (30.0% smaller volumes, p = 0.0381), a trend which primarily affected the rostral-most LC (49.2% smaller average volume, p = 0.0381). We show histopathology data on both the LC and neighboring dorsal raphe caudal (DRc), which were assessed at multiple rostrocaudal levels and mapped with highly sensitive tau severity spatial matrices. We observed significant LC tau accumulation between BB I and II (37.6% increase, p < 0.0001), which may reflect pathology change prior to presumptive cognitive impairment at BB III. Tau pathology was most severe in the middle portion of the LC (11.3% greater compared to rostral LC, p = 0.0289) when including BB III. We noted a significant rostrocaudal gradient of DRc tau severity (58.2% decrease between rostral and caudal DRc, p < 0.0001), suggesting selective regional vulnerabilities of both nuclei. Our study represents a rigorous approach to investigating LC and DRc pathology, having multiple histology sections per sublevel and high-resolution MRI to measure the whole LC, without missing slices in a histological only approach. Taken together, our findings provide novel validated data that demonstrate the tau pathology occurring in the LC and DRc during preclinical AD stages, and alongside spatial reconstructions that will serve as valuable references for in vivo LC imaging.
蓝斑(LC)已被确定为一个比大脑皮层更早出现磷酸化tau蛋白病理变化的部位。我们展示了使用高分辨率尸检MRI以及在对照组和蓝斑中最早的Braak和Braak(BB)阶段(BBI - BBII)进行的经过验证的tau组织病理学数据。高分辨率离体MRI提供了一个三维体积(定量),而组织学揭示了tau蛋白的特异性和严重程度负担(半定量)。我们将高度区域特异性的蓝斑数据映射到与组织学中使用的相同样本的高分辨率三维MRI重建上(n = 11)。我们注意到在BB 0和II之间存在显著的结构亚萎缩(体积小30.0%,p = 0.0381),这一趋势主要影响最靠前的蓝斑(平均体积小49.2%,p = 0.0381)。我们展示了蓝斑和相邻的尾侧背缝核(DRc)的组织病理学数据,这些数据在多个前后水平进行了评估,并用高度敏感的tau蛋白严重程度空间矩阵进行了映射。我们观察到在BB I和II之间蓝斑tau蛋白积累显著(增加37.6%,p < 0.0001),这可能反映了在BB III期假定的认知障碍之前的病理变化。当包括BB III期时,tau蛋白病理变化在蓝斑中部最为严重(与靠前的蓝斑相比大11.3%,p = 0.0289)。我们注意到DRc tau蛋白严重程度存在显著的前后梯度(在靠前和靠后的DRc之间减少58.2%,p < 0.0001),表明这两个核团存在选择性区域易损性。我们的研究代表了一种严谨的方法来研究蓝斑和DRc病理,每个亚水平有多个组织学切片以及高分辨率MRI来测量整个蓝斑,避免了仅采用组织学方法时出现的切片遗漏。综上所述,我们的研究结果提供了新的经过验证的数据,证明了在临床前阿尔茨海默病阶段蓝斑和DRc中发生的tau蛋白病理变化,以及空间重建,这些将为活体蓝斑成像提供有价值的参考。